FDA Drugs recall ·
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use… recall
- Recall number
- D-0023-2026
- Date
- (initiated October 9, 2025)
- Company / brand
- STAQ Pharma, Inc.
14135 E 42nd Ave Ste 50, Denver, CO, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Ongoing
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Why was it recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: 25104595A, Expiry: 27DEC2025.
Distribution
Nationwide in the U.S.
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0023-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.